33 yo M with IBD presents with bloody diarrhea


  1. Identify the key features of a presentation that help characterize the severity of an IBD flare
  2. Develop a stepwise approach to in-hospital escalation of UC therapy
  3. Discuss the different clinical manifestations between ulcerative colitis and crohn disease


A 33 year old man with a history of ulcerative colitis presents with 3 weeks of progressively worsening bloody diarrhea (now 8-10 times a day), abdominal cramping, tenesmus, rectal pain and a five pound unintentional weight loss.  He denies fevers, chills, nausea, vomiting or skin changes.  His ulcerative colitis was first diagnosed 2 years ago, staged as mild disease and has been well managed with oral mesalamine.

On exam he is afebrile, HR 110, BP 107/75, RR 20, SpO2 98%.  He appears comfortable with a mildly tender abdomen throughout.  No perianal fistula or palpable fluctuance on external anal exam.  Labs are notable for Na 130, Cr 1.2, WBC 12k, Hct 29%, Plt 250, INR 1.1, nml LFTs, ESR 40, CRP 185.

What key clinical features of this patient’s history help stratify the severity of his IBD?

Staging IBD is important for guiding management and determining prognosis. What tools or classification systems are available for Crohn disease (CD) and ulcerative colitis (UC)?

Let’s review some terminology and treatment options for severe UC by working through the following management pathway.

Given this patient’s clinical presentation, how would you manage him overnight, what work-up would you initiate and what do you anticipate will happen during his hospitalization?

UC and CD have classically been described as separate disorders.  However, they have significant overlap and there is increasing controversy as to whether they are simply different manifestations of the same disease and it may be more appropriate to describe them as IBD with certain distributions and complications (i.e. IBD of distal colon).  What are some of the classic differences between the UC and CD?

In general terms, how does the above UC management pathway potentially differ from that of CD


The patient was admitted to the medicine service for a severe crohn’s flare requiring induction therapy.  His 5-ASA was discontinued and he was initiated on methylprednisalone 60mg IV daily.  A colonoscopy on the following morning revealed pancolitis with friable mucosa and active bleeding.  Testing for c.diff and other enteric pathogens was negative.  His frequency of bowel movements improved to 3-4 non-bloody stools by hospital day 3.  On day four his TPMT activity was still pending and he was discharged on an oral prednisone taper with plans for initiation of AZA with or without a TNF inhibitor in clinic a few weeks later.


  • Frequency of bloody vs. non-bloody stools, evidence of systemic disease (fever, leukocytosis, elevated ESR) and anemia are useful markers for determining severity of an IBD flare
  • UC can be definitively managed with a colectomy while there is no definitive management for CD.
  • Always test TPMT activity prior to initiating AZA given the heterogeneity in rates of metabolization and potential for toxicity.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.